搜尋





搜尋





市場行情
/
股票
/
axsm
/

Axsome Therapeutics Inc

AXSM

添加自選

217.990USD

-16.650-7.10%

收盤 07-31 16:00（美東）報價延遲15分鐘

11.22B總市值

虧損本益比TTM

Axsome Therapeutics Inc

217.990

-16.650-7.10%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

AXSM 利潤表

您可以在這裡找到Axsome Therapeutics Inc的年度或季度收入報告，以深入了解Axsome Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

FY2016Q2

FY2016Q1

FY2015Q4

FY2015Q3

FY2015Q2

FY2015Q1

FY2014Q3

營業總收入

57.42%191.20M

65.03%196.00M

63.22%170.99M

72.13%150.04M

61.95%121.46M

66.04%118.77M

81.27%104.76M

86.65%87.17M

-20.70%75.00M

193.50%71.53M

243.08%57.79M

429.49%46.70M

--94.58M

--24.37M

--16.85M

--8.82M

----

--0.00

----

--0.00

----

營業收入

57.36%189.40M

65.95%194.69M

63.67%169.78M

72.17%148.96M

62.44%120.36M

65.84%117.33M

81.59%103.74M

88.02%86.52M

-21.43%74.10M

190.29%70.75M

239.12%57.13M

421.75%46.02M

--94.30M

--24.37M

--16.85M

--8.82M

----

--0.00

----

--0.00

----

主營業務成本

43.45%16.30M

14.97%13.94M

34.61%13.52M

55.90%15.04M

44.07%11.36M

34.90%12.12M

23.39%10.04M

55.87%9.64M

-13.61%7.89M

130.52%8.98M

130.53%8.14M

224.24%6.19M

--9.13M

--3.90M

--3.53M

--1.91M

----

營業費用

42.98%256.27M

28.62%232.02M

35.05%203.92M

19.51%194.86M

24.74%179.23M

42.50%180.40M

25.73%151.00M

54.25%163.05M

42.11%143.69M

58.07%126.60M

102.52%120.09M

118.57%105.70M

164.08%101.11M

145.61%80.09M

77.51%59.30M

56.77%48.36M

37.51%38.29M

17.53%32.61M

58.13%33.41M

73.51%30.85M

-14.30%27.84M

13.57%27.74M

11.50%21.13M

32.20%17.78M

211.77%32.49M

158.49%24.43M

129.85%18.95M

68.32%13.45M

45.49%10.42M

46.65%9.45M

30.90%8.24M

18.35%7.99M

-6.63%7.16M

-15.49%6.44M

-12.63%6.30M

-1.12%6.75M

30.41%7.67M

141.73%7.63M

256.15%7.21M

227.48%6.83M

204.32%5.88M

--3.15M

19.28%2.02M

--2.08M

--1.93M

--1.70M

研發費用

17.62%52.68M

-11.30%48.79M

-11.51%40.16M

-0.63%49.54M

21.60%44.78M

78.57%55.01M

57.78%45.39M

142.23%49.85M

106.99%36.83M

109.64%30.80M

93.37%28.77M

30.32%20.58M

41.38%17.79M

6.61%14.69M

12.87%14.88M

8.89%15.79M

-24.17%12.59M

-20.73%13.78M

-10.92%13.18M

37.56%14.50M

-39.70%16.60M

-9.48%17.38M

-6.57%14.80M

-4.18%10.54M

261.98%27.52M

168.56%19.21M

162.14%15.84M

98.24%11.00M

59.98%7.60M

59.13%7.15M

35.11%6.04M

10.85%5.55M

-20.60%4.75M

-22.61%4.49M

-19.71%4.47M

-5.49%5.01M

32.23%5.99M

163.00%5.81M

265.31%5.57M

225.35%5.30M

219.59%4.53M

--2.21M

17.12%1.52M

--1.63M

--1.42M

--1.30M

折舊攤銷及損耗

10.97%2.37M

9.70%2.27M

16.98%2.41M

12.69%2.25M

16.49%2.13M

19.14%2.07M

18.24%2.06M

18.00%1.99M

10.17%1.83M

2.83%1.74M

3.72%1.74M

70.01%1.69M

4436.52%1.66M

5350.55%1.69M

6071.38%1.68M

10090.21%993.44K

340.02%36.64K

320.55%31.05K

393.12%27.23K

76.48%9.75K

53.16%8.33K

36.91%7.38K

-41.19%5.52K

-50.28%5.52K

-52.48%5.44K

-55.83%5.39K

-28.20%9.39K

-5.15%11.11K

-4.18%11.44K

8.28%12.21K

21.27%13.08K

12.77%11.71K

18.05%11.94K

15.62%11.27K

91.94%10.78K

245.89%10.39K

378.84%10.11K

679.46%9.75K

400.71%5.62K

247.17%3.00K

594.74%2.11K

--1.25K

--1.12K

--865.00

--304.00

--0.00

營業利潤

-12.63%-65.07M

41.55%-36.02M

28.79%-32.92M

40.94%-44.82M

15.89%-57.77M

-11.92%-61.63M

25.79%-46.23M

-28.61%-75.89M

-950.90%-68.69M

1.17%-55.07M

-46.75%-62.30M

-49.22%-59.00M

82.93%-6.54M

-70.87%-55.72M

-27.08%-42.45M

-28.18%-39.54M

-37.51%-38.29M

-17.53%-32.61M

-58.13%-33.41M

-73.51%-30.85M

14.30%-27.84M

-13.57%-27.74M

-11.50%-21.13M

-32.20%-17.78M

-211.77%-32.49M

-158.49%-24.43M

-129.85%-18.95M

-68.32%-13.45M

-45.49%-10.42M

-46.65%-9.45M

-30.90%-8.24M

-18.35%-7.99M

6.63%-7.16M

15.49%-6.44M

12.63%-6.30M

1.12%-6.75M

-30.41%-7.67M

-141.73%-7.63M

-256.15%-7.21M

-227.48%-6.83M

-204.32%-5.88M

---3.15M

-19.28%-2.02M

---2.08M

---1.93M

---1.70M

淨非營業利息收入（費用）

利息收入

-22.67%1.58M

48.43%3.58M

-33.56%1.94M

-49.44%1.80M

-45.95%2.05M

-42.80%2.41M

-29.49%2.91M

167.02%3.57M

176.22%3.79M

230.96%4.22M

2347.44%4.13M

--1.34M

--1.37M

--1.28M

--168.87K

----

利息費用

-38.19%2.77M

2.83%4.75M

-37.53%3.06M

-25.26%3.64M

-8.03%4.48M

-6.05%4.62M

0.04%4.89M

19.72%4.87M

33.95%4.87M

89.47%4.92M

89.54%4.89M

80.16%4.07M

170.57%3.63M

--2.60M

--2.58M

--2.26M

--1.34M

----

特殊收入（費用）

117.01%1.71M

182.55%9.07M

19.56%-13.19M

-5.69%-2.28M

-44.19%788.00K

74.58%-10.98M

-9206.11%-16.39M

64.32%-2.16M

771.60%1.41M

-928.65%-43.21M

327.35%180.00K

-1781.39%-6.05M

--162.00K

---4.20M

--42.12K

--360.00K

----

--0.00

100.00%0.00

----

--0.00

---1.25M

----

-100.00%0.00

115.79%102.00K

--15.00K

--1.00K

--2.67M

---646.00K

----

100.00%0.00

-100.00%0.00

100.00%0.00

---93.98K

---2.27M

--166.47K

---78.23K

--0.00

其他非經營性收入（費用）

----

--53.58K

-100.00%0.00

----

--0.00

-35.86%139.45K

----

--0.00

4.98%217.42K

----

-100.00%0.00

--207.11K

----

--474.28K

----

--0.00

----

--0.00

稅前利潤

-8.63%-64.54M

62.41%-28.13M

26.89%-47.23M

38.33%-48.93M

13.08%-59.41M

24.40%-74.83M

-2.74%-64.60M

-17.05%-79.34M

-691.35%-68.36M

-61.62%-98.98M

-40.28%-62.88M

-63.58%-67.79M

78.20%-8.64M

-80.24%-61.24M

-28.50%-44.82M

-28.36%-41.44M

-35.45%-39.63M

-16.50%-33.98M

-52.16%-34.88M

-76.16%-32.28M

9.93%-29.26M

-17.57%-29.16M

-19.80%-22.92M

-33.17%-18.33M

-205.29%-32.48M

-158.49%-24.81M

-131.05%-19.14M

-66.19%-13.76M

-121.42%-10.64M

-29.16%-9.60M

-28.73%-8.28M

-16.89%-8.28M

39.89%-4.81M

-1.39%-7.43M

10.58%-6.43M

-3.99%-7.08M

-36.30%-8.00M

-117.80%-7.33M

-57.22%-7.19M

-219.91%-6.81M

-174.09%-5.87M

---3.36M

-1707.91%-4.58M

---2.13M

---2.14M

---253.12K

所得稅

--0.00

405.88%430.00K

--0.00

---960.00K

--0.00

126.15%85.00K

100.00%0.00

-100.00%0.00

---325.00K

---678.00K

---617.00K

--2.58M

----

除稅後利潤

-8.63%-64.54M

61.88%-28.56M

26.89%-47.23M

39.54%-47.97M

13.08%-59.41M

24.06%-74.91M

-3.86%-64.60M

-18.13%-79.34M

-509.35%-68.36M

-61.09%-98.65M

-38.77%-62.20M

-62.10%-67.17M

71.69%-11.22M

-80.24%-61.24M

-28.50%-44.82M

-28.36%-41.44M

-35.45%-39.63M

-16.50%-33.98M

-52.16%-34.88M

-76.16%-32.28M

9.93%-29.26M

-17.57%-29.16M

-19.80%-22.92M

-33.17%-18.33M

-205.29%-32.48M

-158.49%-24.81M

-131.05%-19.14M

-66.19%-13.76M

-121.42%-10.64M

-29.16%-9.60M

-28.73%-8.28M

-16.89%-8.28M

39.89%-4.81M

-1.39%-7.43M

10.58%-6.43M

-3.99%-7.08M

-36.30%-8.00M

-117.80%-7.33M

-57.22%-7.19M

-219.91%-6.81M

-174.09%-5.87M

---3.36M

-1707.91%-4.58M

---2.13M

---2.14M

---253.12K

持續經營利潤

-8.63%-64.54M

61.88%-28.56M

26.89%-47.23M

39.54%-47.97M

13.08%-59.41M

24.06%-74.91M

-3.86%-64.60M

-18.13%-79.34M

-509.35%-68.36M

-61.09%-98.65M

-38.77%-62.20M

-62.10%-67.17M

71.69%-11.22M

-80.24%-61.24M

-28.50%-44.82M

-28.36%-41.44M

-35.45%-39.63M

-16.50%-33.98M

-52.16%-34.88M

-76.16%-32.28M

9.93%-29.26M

-17.57%-29.16M

-19.80%-22.92M

-33.17%-18.33M

-205.29%-32.48M

-158.49%-24.81M

-131.05%-19.14M

-66.19%-13.76M

-121.42%-10.64M

-29.16%-9.60M

-28.73%-8.28M

-16.89%-8.28M

39.89%-4.81M

-1.39%-7.43M

10.58%-6.43M

-3.99%-7.08M

-36.30%-8.00M

-117.80%-7.33M

-57.22%-7.19M

-219.91%-6.81M

-174.09%-5.87M

---3.36M

-1707.91%-4.58M

---2.13M

---2.14M

---253.12K

歸属于母公司的淨利潤

-8.63%-64.54M

61.88%-28.56M

26.89%-47.23M

39.54%-47.97M

13.08%-59.41M

24.06%-74.91M

-3.86%-64.60M

-18.13%-79.34M

-509.35%-68.36M

-61.09%-98.65M

-38.77%-62.20M

-62.10%-67.17M

71.69%-11.22M

-80.24%-61.24M

-28.50%-44.82M

-28.36%-41.44M

-35.45%-39.63M

-16.50%-33.98M

-52.16%-34.88M

-76.16%-32.28M

9.93%-29.26M

-17.57%-29.16M

-19.80%-22.92M

-33.17%-18.33M

-205.29%-32.48M

-158.49%-24.81M

-131.05%-19.14M

-66.19%-13.76M

-121.42%-10.64M

-29.16%-9.60M

-28.73%-8.28M

-16.89%-8.28M

39.89%-4.81M

-1.39%-7.43M

10.58%-6.43M

-3.99%-7.08M

-36.30%-8.00M

-117.80%-7.33M

-57.22%-7.19M

-219.91%-6.81M

-174.09%-5.87M

---3.36M

-1707.91%-4.58M

---2.13M

---2.14M

---253.12K

歸屬普通股東的淨利潤

-8.63%-64.54M

61.88%-28.56M

26.89%-47.23M

39.54%-47.97M

13.08%-59.41M

24.06%-74.91M

-3.86%-64.60M

-18.13%-79.34M

-509.35%-68.36M

-61.09%-98.65M

-38.77%-62.20M

-62.10%-67.17M

71.69%-11.22M

-80.24%-61.24M

-28.50%-44.82M

-28.36%-41.44M

-35.45%-39.63M

-16.50%-33.98M

-52.16%-34.88M

-76.16%-32.28M

9.93%-29.26M

-17.57%-29.16M

-19.80%-22.92M

-33.17%-18.33M

-205.29%-32.48M

-158.49%-24.81M

-131.05%-19.14M

-66.19%-13.76M

-121.42%-10.64M

-29.16%-9.60M

-28.73%-8.28M

-16.89%-8.28M

39.89%-4.81M

-1.39%-7.43M

10.58%-6.43M

-3.99%-7.08M

-36.30%-8.00M

-117.80%-7.33M

-57.22%-7.19M

-219.91%-6.81M

-174.09%-5.87M

---3.36M

-1707.91%-4.58M

---2.13M

---2.14M

---253.12K

基本每股收益

-3.69%-1.26

63.45%-0.56

29.64%-0.94

41.82%-0.97

15.71%-1.22

25.93%-1.54

-1.66%-1.34

-8.43%-1.67

-459.58%-1.44

-47.91%-2.08

-22.82%-1.32

-45.06%-1.54

75.08%-0.26

-56.56%-1.41

-16.10%-1.07

-23.47%-1.06

-32.29%-1.03

-15.22%-0.90

-50.67%-0.93

-73.84%-0.86

10.81%-0.78

-9.43%-0.78

-10.60%-0.61

-21.33%-0.49

-172.27%-0.88

-122.36%-0.71

-76.59%-0.56

-26.81%-0.41

-70.83%-0.32

-4.71%-0.32

-15.57%-0.31

-6.94%-0.32

53.95%-0.19

19.90%-0.31

27.55%-0.27

15.60%-0.30

-33.59%-0.41

-62.41%-0.38

-45.48%-0.38

-196.03%-0.36

-59.00%-0.31

---0.24

-1708.40%-0.26

---0.12

---0.19

---0.01

稀釋每股收益

-3.69%-1.26

63.45%-0.56

29.64%-0.94

41.82%-0.97

15.71%-1.22

25.93%-1.54

-1.66%-1.34

-8.43%-1.67

-459.58%-1.44

-47.91%-2.08

-22.82%-1.32

-45.06%-1.54

75.08%-0.26

-56.56%-1.41

-16.10%-1.07

-23.47%-1.06

-32.29%-1.03

-15.22%-0.90

-50.67%-0.93

-73.84%-0.86

10.81%-0.78

-9.43%-0.78

-10.60%-0.61

-21.33%-0.49

-172.27%-0.88

-122.36%-0.71

-76.59%-0.56

-26.81%-0.41

-70.83%-0.32

-4.71%-0.32

-15.57%-0.31

-6.94%-0.32

53.95%-0.19

19.90%-0.31

27.55%-0.27

15.60%-0.30

-33.59%-0.41

-62.41%-0.38

-45.48%-0.38

-196.03%-0.36

-59.00%-0.31

---0.24

-1708.40%-0.26

---0.12

---0.19

---0.01

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Axsome Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 AXSM 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Axsome Therapeutics Inc 財年末的營收是多少？



Axsome Therapeutics Inc 2025 財年營收為 638.50M，高於上一財年的 385.69M。

Axsome Therapeutics Inc 最近一個季度的營收是多少？



Axsome Therapeutics Inc 最近一個季度的營收為 191.20M，同比增長 57.42%。

Axsome Therapeutics Inc 全年的淨利潤是多少？



Axsome Therapeutics Inc 2025 財年淨利潤為 -183.17M。

Axsome Therapeutics Inc 上一季度的淨利潤是多少？



Axsome Therapeutics Inc 最近一個季度的淨利潤為 -64.54M。

Axsome Therapeutics Inc 年度營業利潤是多少？



Axsome Therapeutics Inc 2025 財年的營業利潤為 -171.53M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。